TCRX – tscan therapeutics, inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TCRX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

10:53 am

tcrx

TScan Therapeutics (NASDAQ:TCRX) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.

Low Report

TScan Therapeutics (NASDAQ:TCRX) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.

Report

11/14

10:53 am

tcrx

TScan Therapeutics (NASDAQ:TCRX) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.

Low Report

TScan Therapeutics (NASDAQ:TCRX) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.

Report

11/13

07:50 pm

tcrx

TScan Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley

Report

TScan Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley

Report

11/13

07:50 pm

tcrx

TScan Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley

Report

TScan Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.